There is a new dual-lead pacemaker with leads projecting over the expected locations. There is volume loss in both lower lungs and bilateral pleural effusions. There is mild pulmonary vascular redistribution. An underlying infectious infiltrate in the lower lobes cannot be excluded. Compared to the prior study the fluid status is slightly worse.